Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

YKL-40 promotes proliferation of CTCL tumor cells through extracellular signal-regulated kinase pathways.

Suzuki H, Boki H, Kamijo H, Nakajima R, Oka T, Shishido-Takahashi N, Suga H, Sugaya M, Sato S, Miyagaki T.

J Invest Dermatol. 2019 Oct 14. pii: S0022-202X(19)33298-1. doi: 10.1016/j.jid.2019.09.007. [Epub ahead of print]

PMID:
31622598
2.

Assessing subclinical inflammation by peroxidase detection in patients with pressure ulcers.

Kitamura A, Minematsu T, Nakagami G, Miyagaki T, Sasaki S, Hayashi C, Sanada H.

J Wound Care. 2019 Sep 2;28(9):586-591. doi: 10.12968/jowc.2019.28.9.586.

PMID:
31513504
3.

Increased interleukin-26 expression promotes Th17 and Th2-associated cytokine production by keratinocytes in atopic dermatitis.

Kamijo H, Miyagaki T, Hayashi Y, Akatsuka T, Watanabe-Otobe S, Oka T, Shishido-Takahashi N, Suga H, Sugaya M, Sato S.

J Invest Dermatol. 2019 Aug 26. pii: S0022-202X(19)33148-3. doi: 10.1016/j.jid.2019.07.713. [Epub ahead of print]

PMID:
31465744
4.

Increased Serum Activin A Levels in Mycosis Fungoides and Sézary Syndrome.

Oka T, Miyagaki T, Kamijo H, Nakajima R, Shishido-Takahashi N, Senda N, Suga H, Sugaya M, Sato S.

Acta Derm Venereol. 2019 Jun 26. doi: 10.2340/00015555-3246. [Epub ahead of print] No abstract available.

5.

Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome.

Oka T, Miyagaki T.

Front Med (Lausanne). 2019 May 29;6:116. doi: 10.3389/fmed.2019.00116. eCollection 2019. Review.

6.

Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.

Shono Y, Suga H, Kamijo H, Fujii H, Oka T, Miyagaki T, Shishido-Takahashi N, Sugaya M, Sato S.

Acta Derm Venereol. 2019 Jul 1;99(9):809-812. doi: 10.2340/00015555-3207.

7.

YKL-40 augments the proliferation of HaCaT cells via the extracellular regulatory kinase pathway.

Suzuki H, Miyagaki T, Sato S.

J Dermatol. 2019 Jun;46(6):551-552. doi: 10.1111/1346-8138.14898. Epub 2019 Apr 25. No abstract available.

PMID:
31021016
8.

Osteogenic melanoma of the right fifth toe.

Hayashi Y, Masui Y, Miyagawa T, Yamada D, Miyagaki T, Ikegami M, Kobayashi H, Shinozaki-Ushiku A, Takekoshi T, Sato S.

J Dermatol. 2019 Jul;46(7):e265-e266. doi: 10.1111/1346-8138.14822. Epub 2019 Feb 27. No abstract available.

PMID:
30811057
9.

Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.

Kamata M, Asano Y, Shida R, Maeda N, Yoshizaki A, Miyagaki T, Kawashima T, Tada Y, Sato S.

J Dermatol. 2019 Jun;46(6):e216-e217. doi: 10.1111/1346-8138.14760. Epub 2019 Jan 10. No abstract available.

PMID:
30628103
10.

Case of purpuric drug eruption probably induced by panitumumab.

Senda N, Miyagaki T, Oka T, Nonogaki A, Yoshizaki A, Shibata S, Sato S.

J Dermatol. 2019 Jun;46(6):e221-e222. doi: 10.1111/1346-8138.14724. Epub 2018 Dec 7. No abstract available.

PMID:
30537161
11.

Decreased progranulin expression in Mycosis fungoides: a possible association with the high frequency of skin infections.

Nakajima R, Miyagaki T, Kamijo H, Oka T, Shishido-Takahashi N, Suga H, Sugaya M, Sato S.

Eur J Dermatol. 2018 Dec 1;28(6):790-794. doi: 10.1684/ejd.2018.3452.

PMID:
30530405
12.

A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.

Miyagawa T, Asano Y, Saigusa R, Hirabayashi M, Yamashita T, Taniguchi T, Takahashi T, Nakamura K, Miura S, Yoshizaki A, Miyagaki T, Sato S.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):753-760. doi: 10.1111/jdv.15387. Epub 2019 Jan 1.

PMID:
30520152
13.

Sézary syndrome without erythroderma: A case report and review of published work.

Kamijo H, Miyagaki T, Norimatsu Y, Shishido-Takahashi N, Kuzumi A, Asano Y, Sato S.

J Dermatol. 2019 Jan;46(1):61-64. doi: 10.1111/1346-8138.14692. Epub 2018 Oct 31. Review.

PMID:
30379353
14.

Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma.

Senda N, Miyagaki T, Oka T, Itoigawa A, Kikuchi K, Kobayashi T, Nakamura F, Kurokawa M, Sugaya M, Sato S.

J Dermatol. 2019 May;46(5):e161-e163. doi: 10.1111/1346-8138.14701. Epub 2018 Oct 31. No abstract available.

PMID:
30379350
15.

Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.

Senda N, Miyagaki T, Kamijo H, Nakajima R, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

Eur J Dermatol. 2018 Oct 1;28(5):621-627. doi: 10.1684/ejd.2018.3400.

PMID:
30378541
16.

Japanese familial anetoderma: A report of two cases and review of the published work.

Fukayama M, Miyagaki T, Akamata K, Suzuki S, Tanaka M, Sato S.

J Dermatol. 2018 Dec;45(12):1459-1462. doi: 10.1111/1346-8138.14672. Epub 2018 Oct 15. Review.

PMID:
30320485
17.

Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.

Suzuki H, Sugaya M, Nakajima R, Oka T, Takahashi N, Nakao M, Miyagaki T, Asano Y, Sato S.

J Dermatol. 2018 Dec;45(12):1440-1443. doi: 10.1111/1346-8138.14665. Epub 2018 Oct 5.

PMID:
30289574
18.

Color Doppler Ultrasonography to Evaluate Hypoechoic Areas in Pressure Ulcers: A Report of Two Cases.

Yabunaka K, Nakagami G, Miyagaki T, Sasaki S, Hayashi C, Sanada H.

J Med Ultrasound. 2018 Jul-Sep;26(3):163-165. doi: 10.4103/JMU.JMU_60_18. Epub 2018 Sep 14.

19.

Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.

Yamashita T, Asano Y, Saigusa R, Taniguchi T, Nakamura K, Miura S, Toyama T, Takahashi T, Ichimura Y, Hirabayashi M, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol Sci. 2019 Jan;93(1):24-32. doi: 10.1016/j.jdermsci.2018.09.007. Epub 2018 Sep 21.

PMID:
30270117
20.

Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.

Kamijo H, Miyagaki T, Shishido-Takahashi N, Nakajima R, Oka T, Suga H, Sugaya M, Sato S.

Blood. 2018 Nov 1;132(18):1922-1935. doi: 10.1182/blood-2018-04-845834. Epub 2018 Sep 7.

PMID:
30194255
21.

Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.

Akatsuka T, Miyagaki T, Nakajima R, Kamijo H, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

Eur J Dermatol. 2018 Jun 1;28(3):314-319. doi: 10.1684/ejd.2018.3319.

PMID:
29952298
22.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2019 Mar 1;30(3):494. doi: 10.1093/annonc/mdy207. No abstract available.

PMID:
29947731
23.

Methotrexate-associated lymphoproliferative disorder presenting as giant ulcers on the leg.

Oka T, Miyagaki T, Nakamura R, Funamizu K, Sugaya M, Ebisawa K, Koya J, Kurokawa M, Sato S.

Clin Exp Dermatol. 2018 Dec;43(8):930-933. doi: 10.1111/ced.13660. Epub 2018 May 31. No abstract available.

PMID:
29855057
24.

Paraneoplastic arthritis in a patient with Sézary syndrome.

Kuzumi A, Takahashi-Shishido N, Mukogawa S, Miyagaki T, Sato S.

Int J Dermatol. 2018 Aug;57(8):e57-e58. doi: 10.1111/ijd.14020. Epub 2018 May 4. No abstract available.

PMID:
29726614
25.

Linear immunoglobulin A bullous dermatosis limited to oral mucosa associated with ulcerative colitis.

Oka T, Miyagaki T, Isomura S, Ichimura Y, Kamata M, Mitsui H, Ishii N, Hashimoto T, Sato S.

J Dermatol. 2018 Oct;45(10):e281-e282. doi: 10.1111/1346-8138.14326. Epub 2018 Apr 14. No abstract available.

PMID:
29655262
26.

Exacerbated Immune Complex-Mediated Vascular Injury in Mice with Heterozygous Deficiency of Aryl Hydrocarbon Receptor through Upregulation of Fcγ Receptor III Expression on Macrophages.

Nakajima R, Miyagaki T, Morimura S, Fukasawa T, Oka T, Yoshizaki A, Sugaya M, Sato S.

J Invest Dermatol. 2018 Oct;138(10):2195-2204. doi: 10.1016/j.jid.2018.03.1520. Epub 2018 Mar 30.

27.

Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.

Oka T, Miyagaki T, Takahashi N, Nakajima R, Kamijo H, Suga H, Asano Y, Sugaya M, Sato S.

J Invest Dermatol. 2018 Oct;138(10):2286-2288. doi: 10.1016/j.jid.2018.03.1519. Epub 2018 Mar 30. No abstract available.

28.

Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma.

Kurano M, Miyagaki T, Miyagawa T, Igarashi K, Shimamoto S, Ikeda H, Aoki J, Sato S, Yatomi Y.

J Dermatol. 2018 May;45(5):571-579. doi: 10.1111/1346-8138.14278. Epub 2018 Mar 3.

PMID:
29500864
29.

Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.

Otobe S, Sugaya M, Nakajima R, Oka T, Takahashi N, Kabasawa M, Miyagaki T, Asano Y, Sato S.

J Dermatol. 2018 Apr;45(4):468-471. doi: 10.1111/1346-8138.14198. Epub 2018 Jan 3.

PMID:
29314201
30.

Interleukin-25 is involved in cutaneous T-cell lymphoma progression by establishing a T helper 2-dominant microenvironment.

Nakajima R, Miyagaki T, Hirakawa M, Oka T, Takahashi N, Suga H, Yoshizaki A, Fujita H, Asano Y, Sugaya M, Sato S.

Br J Dermatol. 2018 Jun;178(6):1373-1382. doi: 10.1111/bjd.16237. Epub 2018 Mar 23.

PMID:
29238954
31.

Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.

Hirabayashi M, Asano Y, Yamashita T, Miura S, Nakamura K, Taniguchi T, Saigusa R, Takahashi T, Ichimura Y, Miyagawa T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol. 2018 Feb;45(2):182-188. doi: 10.1111/1346-8138.14088. Epub 2017 Oct 17.

PMID:
29044628
32.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2017 Oct 1;28(10):2517-2525. doi: 10.1093/annonc/mdx352.

PMID:
28961843
33.

Dermatofibrosarcoma Protuberans Presenting as a Large Atrophic Plaque on the Chest.

Saigusa R, Miyagawa T, Toyama S, Omatsu J, Miyagaki T, Masui Y, Yamada D, Sato S.

Acta Derm Venereol. 2018 Jan 12;98(1):155-156. doi: 10.2340/00015555-2800. No abstract available.

34.

Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome.

Sakamoto M, Miyagaki T, Kamijo H, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

J Dermatol. 2018 Jan;45(1):95-99. doi: 10.1111/1346-8138.14033. Epub 2017 Sep 19.

PMID:
28925057
35.

Increased endocan expression in lesional skin and decreased endocan expression in sera in atopic dermatitis.

Suzuki H, Miyagaki T, Otobe S, Nakajima R, Oka T, Takahashi N, Kabasawa M, Suga H, Yoshizaki A, Asano Y, Sato S, Sugaya M.

J Dermatol. 2017 Dec;44(12):1392-1395. doi: 10.1111/1346-8138.13974. Epub 2017 Jul 17.

PMID:
28714079
36.

Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.

Oka T, Sugaya M, Takahashi N, Nakajima R, Otobe S, Kabasawa M, Suga H, Miyagaki T, Asano Y, Sato S.

Acta Derm Venereol. 2017 Nov 15;97(10):1172-1177. doi: 10.2340/00015555-2723.

37.

BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines.

Kamijo H, Sugaya M, Takahashi N, Oka T, Miyagaki T, Asano Y, Sato S.

Arch Dermatol Res. 2017 Aug;309(6):491-497. doi: 10.1007/s00403-017-1749-9. Epub 2017 Jun 7.

PMID:
28593508
38.

Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.

Saigusa R, Asano Y, Nakamura K, Hirabayashi M, Miura S, Yamashita T, Taniguchi T, Ichimura Y, Takahashi T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Invest Dermatol. 2017 Sep;137(9):1850-1859. doi: 10.1016/j.jid.2017.04.035. Epub 2017 May 18.

39.

Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis.

Miyagawa T, Asano Y, de Mestier Y, Saigusa R, Taniguchi T, Yamashita T, Nakamura K, Hirabayashi M, Miura S, Ichimura Y, Takahashi T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol. 2017 Oct;44(10):1168-1171. doi: 10.1111/1346-8138.13877. Epub 2017 Apr 22.

PMID:
28432700
40.

Adult T-cell leukemia/lymphoma with subungual hematomas in all fingers and toes as the first manifestation.

Otobe S, Sugaya M, Taniguchi T, Miyagaki T, Iozumi K, Sato S.

J Dermatol. 2018 Mar;45(3):378-379. doi: 10.1111/1346-8138.13857. Epub 2017 Apr 22. No abstract available.

PMID:
28432688
41.

Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.

Takahashi N, Sugaya M, Suga H, Oka T, Kawaguchi M, Miyagaki T, Fujita H, Inozume T, Sato S.

J Invest Dermatol. 2017 Aug;137(8):1766-1773. doi: 10.1016/j.jid.2017.03.025. Epub 2017 Apr 7.

42.

CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.

Oka T, Sugaya M, Takahashi N, Takahashi T, Shibata S, Miyagaki T, Asano Y, Sato S.

J Immunol. 2017 May 15;198(10):3897-3908. doi: 10.4049/jimmunol.1601607. Epub 2017 Apr 7.

43.

Case of mycosis fungoides with gastric and central nervous system involvement.

Senda N, Miyagaki T, Oka T, Ito Y, Katayama K, Kamiyama T, Sugaya M, Sato S.

J Dermatol. 2017 Jul;44(7):e166-e167. doi: 10.1111/1346-8138.13820. Epub 2017 Mar 11. No abstract available.

PMID:
28295506
44.

Inter-rater and intra-rater reliability outcomes of a rapid bacteria counting system with pressure ulcer samples.

Nakagami G, Mori M, Yoshida M, Kitamura A, Hayashi A, Miyagaki T, Sasaki S, Sugama J, Sanada H.

J Wound Care. 2017 Feb;26(Sup2):S27-S31. doi: 10.12968/jowc.2017.26.Sup2.S27.

PMID:
28182537
45.

Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.

Miyagaki T, Sugaya M, Oka T, Takahashi N, Kawaguchi M, Suga H, Fujita H, Yoshizaki A, Asano Y, Sato S.

Acta Derm Venereol. 2017 May 8;97(5):586-592. doi: 10.2340/00015555-2623.

46.

Biofilm detection by wound blotting can predict slough development in pressure ulcers: A prospective observational study.

Nakagami G, Schultz G, Gibson DJ, Phillips P, Kitamura A, Minematsu T, Miyagaki T, Hayashi A, Sasaki S, Sugama J, Sanada H.

Wound Repair Regen. 2017 Jan;25(1):131-138. doi: 10.1111/wrr.12505. Epub 2017 Feb 7.

PMID:
28019691
47.

Pazopanib induced a partial response in a patient with metastatic fibrosarcomatous dermatofibrosarcoma protuberans without genetic translocations resistant to mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy and gemcitabine-docetaxel chemotherapy.

Miyagawa T, Kadono T, Kimura T, Saigusa R, Yoshizaki A, Miyagaki T, Yamada D, Masui Y, Fujita H, Sato S.

J Dermatol. 2017 Mar;44(3):e21-e22. doi: 10.1111/1346-8138.13717. Epub 2016 Dec 18. No abstract available.

PMID:
27988943
48.

Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.

Abe F, Kitadate A, Ikeda S, Yamashita J, Nakanishi H, Takahashi N, Asaka C, Teshima K, Miyagaki T, Sugaya M, Tagawa H.

Oncotarget. 2017 Jan 31;8(5):7572-7585. doi: 10.18632/oncotarget.13810.

49.

Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma.

Takahashi N, Sugaya M, Suga H, Oka T, Kawaguchi M, Miyagaki T, Fujita H, Sato S.

Cancer Res. 2016 Nov 1;76(21):6241-6252. Epub 2016 Sep 6.

50.

Alopecia areata, thyroiditis and vitiligo vulgaris in a Japanese patient with smoldering type adult T-cell leukemia/lymphoma.

Takahashi N, Sugaya M, Oka T, Miyagaki T, Sato S.

J Dermatol. 2017 Apr;44(4):e79-e80. doi: 10.1111/1346-8138.13582. Epub 2016 Sep 21. No abstract available.

PMID:
27651025

Supplemental Content

Loading ...
Support Center